biotech deals

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

Gilead and Kites exhibit booth at ASH 2025

Gilead's $2.2B Ouro buy delivers TCE, new purpose for Galapagos

Mar 24, 2026 3:34am

Astellas ends $1.6B biobucks TCE pact with CytomX after 6 years

Mar 16, 2026 10:12am

One extinguished candle on dark background

Biotech unit Pfizer Ignite flames out

Mar 12, 2026 3:58pm

French biotech pens $128M deal for Kezar protein degrader work

Mar 12, 2026 9:00am

Boehringer axes MASH deal after OSE asset fails to show efficacy

Mar 2, 2026 2:16pm